Skip to main content
. Author manuscript; available in PMC: 2020 Sep 8.
Published in final edited form as: J Surg Res. 2019 May 27;243:1–7. doi: 10.1016/j.jss.2019.04.086

Fig –

Fig –

Patients with malignant pheochromocytomas and paragangliomas were found to have lower serum expression levels of miR-1210 than patients with benign pheochromocytomas and paragangliomas.